Sign into an existing account

['Bad Optics' Or Something More? Moderna Executives' Stock Sales Raise Concerns
](https://www.npr.org/2020/09/04/908305074/bad-optics-or-something-more-moderna-executives-stock-sales-raise-concerns)

[Moderna failed to disclose federal support in vaccine patents, researchers say
](https://webcache.googleusercontent.com/search?q=cache:9nAm-RFtmYcJ:https://www.washingtonpost.com/business/2020/08/28/moderna-vaccine-patents-darpa-funding/+&cd=8&hl=en&ct=clnk&gl=us)

"Moderna was founded in 2010 and has yet to win market approval of a drug. But its vaccine technology, which has been developed with a combination of U.S. taxpayer support and a large share of private investment, allowed it to be the first company to test its SARS-CoV-2 vaccine in humans."..

"...That research was supported with grants of about $25 million by the Defense Advanced Research Projects Agency (DARPA)...Moderna has not listed that government support in any patents, despite a requirement in the 1980 Bayh-Dole Act that companies disclose in patent applications when they have received government help, KEI said. Moderna also has not disclosed government involvement in any of 154 pending patent applications, KEI’s report said.

The government has never stripped patent rights from a pharmaceutical company under Bayh-Dole, so such as step is highly unlikely, especially since Moderna is working in a close partnership with Trump’s Operation Warp Speed in a bid to halt the current pandemic.

The news site Axios reported on Aug. 5, based on research by KEI and Public Citizen, that Moderna had not disclosed government funding in its news releases as required by government contracts. Axios reported that the Department of Health and Human Services subsequently reminded Moderna of its disclosure obligations."